EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

Cesar U Monjaras-Avila iD, Ana C Lorenzo-Leal iD, Ana C Luque-Badillo iD, Ninadh D'Costa, Claudia Chavez-Muñoz, Horacio Bach iD

International Journal of Molecular Sciences · 27.04.2023 · 24 (9) · 7946

DOI: 10.3390/ijms24097946 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.04.2023. Verfasst von Cesar U Monjaras-Avila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, 2635 Laurel Street, Vancouver, BC V6H 3Z6, Canada. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Antibody Engineering and Proteomics Facility, Immunity and Infection Research Centre, Vancouver, BC, Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is a type of kidney cancer that arises from the cells lining the tubes of the kidney. The tumor immune microenvironment (TIME) of ccRCC is a complex interplay of various immune cells, cytokines, and signaling pathways. One of the critical features of the ccRCC TIME is the presence of infiltrating immune cells, including T cells, B cells, natural killer cells, dendritic cells, and myeloid-derived suppressor cells. Among these cells, CD8+ T cells are particularly important in controlling tumor growth by recognizing and killing cancer cells. However, the TIME of ccRCC is also characterized by an immunosuppressive environment that hinders the function of immune cells. Several mechanisms contribute to the immunosuppressive nature of the ccRCC TIME. For instance, ccRCC cells produce cytokines such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), which suppress immune cell activation and promote the differentiation of regulatory T cells (Tregs). Tregs, in turn, dampen the activity of effector T cells and promote tumor growth. In addition, ccRCC cells can express programmed death-ligand 1 (PD-L1), which interacts with the programmed cell death protein 1 (PD-1) receptor on T cells to inhibit their function. In addition, other immune checkpoint proteins, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and lymphocyte activation gene 3 (LAG-3), also contribute to the immunosuppressive milieu of the ccRCC TIME. Finally, the hypoxic and nutrient-poor microenvironment of ccRCC can stimulate the production of immunosuppressive metabolites, such as adenosine and kynurenine, which further impair the function of immune cells. Understanding the complex interplay between tumor cells and the immune system in the ccRCC TIME is crucial for developing effective immunotherapies to treat this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansCD8-Positive T-LymphocytesT-Lymphocytes, RegulatoryCytokinesTumor Microenvironment

Stichwörter der Autor:innen

TIMEccRCCclear cell renal cell carcinomamccRCCmetastatic clear cell renal cell carcinomarenal cancertumor immune microenvironment

Substanzen

Cytokines

Autor:innen und Institutionen

  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, 2635 Laurel Street, Vancouver, BC V6H 3Z6, Canada.
  • Division of Infectious Diseases, Department of Medicine, University of British Columbia, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada.

ORCID-Profile: Cesar U Monjaras-Avila, Ana C Lorenzo-Leal, Ana C Luque-Badillo, Horacio Bach

Förderung

  • Antibody Engineering and Proteomics Facility, Immunity and Infection Research Centre, Vancouver, BC, Canada

Zitieren

APA

Monjaras-Avila, C. U., Lorenzo-Leal, A. C., Luque-Badillo, A. C., D'Costa, N., Chavez-Muñoz, C., & Bach, H. (2023). The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences, 24(9), 7946. https://doi.org/10.3390/ijms24097946

Vancouver

Monjaras-Avila CU, Lorenzo-Leal AC, Luque-Badillo AC, D'Costa N, Chavez-Muñoz C, Bach H. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 2023;24(9):7946. doi:10.3390/ijms24097946

BibTeX
@article{MonjarasAvila2023,
  author = {Monjaras-Avila, Cesar U and Lorenzo-Leal, Ana C and Luque-Badillo, Ana C and D'Costa, Ninadh and Chavez-Muñoz, Claudia and Bach, Horacio},
  title = {The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {7946},
  doi = {10.3390/ijms24097946}
}
Kostenlos starten →